An unusually high level of quinolone resistance associated with type II topoisomerase mutations in quinolone resistance-determining regions of Aeromonas caviae isolated from diarrhoeal patients

Research in Microbiology

Volumn 155, Issue 10, 2004, Pages 827-829

  Sinha, Sutapa ^a   Chattopadhyay, S ^a   Bhattacharya, S K ^a   Nair, G B ^b   Ramamurthy, T ^a  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

Aeromonas caviae; Mutations; Quinolones; Resistance

Indexed keywords

CIPROFLOXACIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AEROMONAS PUNCTATA; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DIARRHEA; DISEASE PREDISPOSITION; GENE MUTATION; GENETIC ANALYSIS; HOSPITALIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

AEROMONAS; ANTI-INFECTIVE AGENTS; BASE SEQUENCE; CIPROFLOXACIN; DIARRHEA; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; NORFLOXACIN;

AEROMONAS; AEROMONAS PUNCTATA;

EID: 9644260437     PISSN: 09232508     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resmic.2004.06.008     Document Type: Article

References (12)

1. A.M. Carnahan, and M. Altwegg Taxonomy B. Austin M. Altwegg P.J. Gosling S. Joseph The Genus Aeromonas 1996 Wiley New York 1 38
2. J. Garau, M. Xercavins, M. Rodriguez- Carballeira, J.R. Gomez-Vera, L. Coll, D. Vidal, T. Llovet, and A. Ruiz-Bremon Emergence and dissemination of quinolone-resistant Escherichia coli in the community Antimicrob. Agents Chemother. 43 1999 2736 2741
3. P. Garg, S. Sinha, R. Chakraborty, S.K. Bhattacharya, G.B. Nair, and T. Ramamurthy Emergence of fluoroquinolone-resistant strains of Vibrio cholerae O1 biotype ElTor among hospitalized patients with cholera in Calcutta, India Antimicrob. Agents Chemother. 45 2001 1605 1606
4. P. Heisig Genetic evidence for a role of parC mutation in development of high-level fluoroquinolone resistance in Escherichia coli Antimicrob. Agents Chemother. 40 1996 879 885
5. D.C. Hooper Mechanisms of quinolone resistance Drug. Resist. Up-date 2 1999 38 55
6. B.L. Jones, and M.H. Wilcox Aeromonas infections and their treatment J. Antimicrob. Chemother. 35 1995 453 461
7. S.M. Kirov Aeromonas and Plesiomonas M.P. Doyle L.R. Beuchat T.J. Montville Food Microbiology Fundamentals and Frontiers 1997 American Society for Microbiology Washington, DC 265 287
8. National Committee for Clinical Laboratory Standards, Performance Standards for Antimicrobiol Susceptibility Testing, 12th Informational Supplement, NCCLS document M100-S12, National Committee for Clinical Laboratory Standards, Wayne, PA, 2002
9. L.J.V. Piddock Mechanisms of resistance to fluoroquinolones: State-of-the-art 1992-1994 Drugs 49 Suppl. 2 1995 29 35
10. K. Sarkar, S. Ghose, S.K. Niyogi, and S.K. Bhattacharya Shigella dysenteriae type I with reduced susceptibility to fluoroquinolones Lancet 15 2003 361 785
11. M.G. Urriza, C. Arpin, M. Capdepuy, V. Dubois, P. Caumette, and C. Quentin Type II topoisomerase quinolone resistance-determining regions of Aeromonas caviae, A. hydrophila and A. sobria complexes and mutations associated with quinolone resistance Antimicrob. Agents Chemother. 46 2002 350 359
12. M.G. Urriza, L. Pineau, M. Capdepuy, C. Roques, P. Caumette, and C. Quentin Antimicrobial resistance of mesophilic Aeromonas spp. isolated from two European rivers J. Antimicrob. Chemother. 46 2002 297 301